2012 Mar Evgeny Pokushalov, Andrey Ponomarenko, Sevda Bayramova, Claire Garcia, Inessa Pak, Evgenya Shrainer, Marina Ermolaeva, Dmitry Kudlay, Michael Johnson, Richard Miller
The aim of this collaboration is to model the target mRNA and jointly explore sequence space and novel chemical modifications to enhance efficacy and therapeutic effects, while predicting the optimal therapeutic candidate molecules in preclinical models for further development by AInyiam, thereby promoting advances in SiRNA design
BioHelp is a family owned and operated nutraceutical distribution company
Semin Hematol 1971
These hybrid protocols work especially well for people who respond to injections but want to reduce shot frequency
Disclaimer: IV therapy at California Infusion Centers is intended to support hydration and nutrient balance